Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Suay Hong Gan"'
Autor:
Sze Ling Chan, Angeline Poh Gek Chua, Folefac Aminkeng, Cynthia Bin Eng Chee, Shengnan Jin, Marie Loh, Suay Hong Gan, Yee Tang Wang, Liam R Brunham
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186200 (2017)
Isoniazid (INH) is part of the first-line-therapy for tuberculosis (TB) but can cause drug-induced liver injury (DILI). Several candidate single nucleotide polymorphisms (SNPs) have been previously identified but the clinical utility of these SNPs in
Externí odkaz:
https://doaj.org/article/27353b8661e9417d92a67959f055d015
Autor:
Chen Bai, Jia Mei Hong, Tuan Zea Tan, Alvin Dingyuan Wang, Paul A. Tambyah, Suay Hong Gan, Hoi Wah She, Alicia Tay, Catherine W.M. Ong, Felicia Teo, Josephine Lum, Yu Wang, Amit Singhal, Andres F. Vallejo, Marta E Polak, Yee Tang Wang, Nicholas I. Paton, Qing Hao Miow, Cynthia B.E. Chee, Paul T. Elkington, Jon S. Friedland, Hong Rong Loh, Ying Ding
Publikováno v:
J Clin Invest
BACKGROUND: Matrix metalloproteinases (MMPs) are key regulators of tissue destruction in tuberculosis (TB) and may be targets for host-directed therapy. We conducted a phase II double-blind, randomized, controlled trial investigating doxycycline, a l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cde4a7f1352470ce765cbbda6b8babfe
https://europepmc.org/articles/PMC8321570/
https://europepmc.org/articles/PMC8321570/
Autor:
Yee Tang Wang, Suay Hong Gan, Cynthia B.E. Chee, Li Hwei Sng, Kyi Win KhinMar, Leo Kang Yang Lim, Li Wei Ang
Publikováno v:
Open Forum Infectious Diseases
Background Previously treated (ie, recurrent) tuberculosis (TB) cases account for approximately 7%–8% of incident TB globally and in Singapore. Molecular fingerprinting has enabled the differentiation of these patients into relapsed or reinfection
Autor:
Leo Kang Yang Lim, Angeline Poh-Gek Chua, S. Tan, Suay-Hong Gan, Li-Hwei Sng, Cynthia B.E. Chee, Yee-Tang Wang
Publikováno v:
D26. CLINICAL AND EPIDEMIOLOGICAL DEVELOPMENTS IN TB.
Autor:
Cynthia B.E. Chee, Suay-Hong Gan, Rick T. Ong, Li-Hwei Sng, Christopher W. Wong, Jeffery Cutter, Min Gong, Hui-Maan Seah, Li Yang Hsu, Suhana Solhan, Peng-Lim Ooi, Eryu Xia, Jayne T. Lim, Chwee-Kim Koh, Soon-Kok Lim, Han-Kee Lim, Yee-Tang Wang
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 1, Pp 179-180 (2015)
Externí odkaz:
https://doaj.org/article/4dd08706ec4e4623b872307ac7fc7a65
Publikováno v:
Tuberculosis.
Background: Globally, about 80% of rifampicin-resistant (RR) tuberculosis (TB) are also resistant to isoniazid. Thus, it is taken as a surrogate marker of multi-drug resistant (MDR) TB. Aim: The objective of this study is to determine the incidence o
Publikováno v:
Tuberculosis.
Autor:
Angeline Poh Gek Chua, Suay Hong Gan, Cynthia B.E. Chee, Sze Ling Chan, Yee Tang Wang, Marie Loh, Liam R. Brunham, Shengnan Jin, Folefac Aminkeng
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 10, p e0186200 (2017)
PLoS ONE, Vol 12, Iss 10, p e0186200 (2017)
BACKGROUND AND AIMS Isoniazid (INH) is part of the first-line-therapy for tuberculosis (TB) but can cause drug-induced liver injury (DILI). Several candidate single nucleotide polymorphisms (SNPs) have been previously identified but the clinical util
Autor:
Yee Tang Wang, Leo Kang Yang Leo, Kyi Win KhinMar, Suay Hong Gan, Cynthia B.E. Chee, Vernon J. Lee
Publikováno v:
Tuberculosis.
Background: About 6-8% of tuberculosis (TB)cases occurring among Singapore residents have a previous history of TB. Objective: To study the risk factors for recurrent TB and the contribution of re-infection in our residents where the majority of pati
Publikováno v:
Tuberculosis.